The state purchased medicines worth 864.3 billion rubles. in 2023 – Kommersant

At the end of 2023, the volume of drug purchases by the state amounted to 864.3 billion rubles. This is 7% lower than in 2022 (929.4 billion rubles), reports RBC with reference to data from the analytical company Headway Company. The Ministry of Health denies the reduction in government procurement.

We are talking about drugs purchased at both the federal and regional levels. According to Headway Company estimates, from 2018 to 2022, the monetary volume of government purchases of medicines increased. After government purchases decreased by 4.8% – from 974.6 billion rubles. in 2021 to 929.4 billion rubles. in 2022. Experts explain this by the cancellation of purchases of drugs for the treatment of coronavirus in 2022. In 2023, the volumes of federal purchases that provided medicines, including for patients with serious illnesses, fell the most.

The press service of the Ministry of Health claims that the volume of government contracts concluded in 2023 for the supply of medicines, on the contrary, increased by more than 36 billion rubles. year to year. The department clarified that the assessment is based on the volume of limits on budget obligations (that is, funds provided by the budget). The mentioned 36 billion rubles. may include contracts entered into in 2022, but for which deliveries continued into 2023.

As Headway Company calculated for Kommersant, in January-November 2023, almost 36 billion rubles worth of sugar-lowering drugs for patients with type 2 diabetes were purchased using budget funds, which is 66% more year-on-year. Experts explain this by the regions increasing purchases in anticipation of a possible shortage of modern drugs produced by Western pharmaceutical companies, and by an increase in the number of Russians suffering from diabetes.

Details – in the material “Kommersant” “Diabetes has a budget outlined”.

Laura Keffer